| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 9.903 | 17.786 | 20.102 | 20.271 | 37.678 | 66.188 | 44.725 | 40.367 |
| Total Income - EUR | - | - | 9.903 | 17.786 | 20.102 | 20.271 | 37.678 | 66.188 | 44.725 | 40.367 |
| Total Expenses - EUR | - | - | 5.220 | 16.186 | 16.920 | 12.192 | 15.771 | 30.649 | 28.845 | 40.454 |
| Gross Profit/Loss - EUR | - | - | 4.683 | 1.600 | 3.182 | 8.079 | 21.907 | 35.539 | 15.880 | -87 |
| Net Profit/Loss - EUR | - | - | 4.386 | 1.066 | 2.579 | 7.517 | 20.905 | 34.110 | 15.500 | -1.298 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Nevromed Activ Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 1.000 | 805 | 617 | 2.588 | 136.324 | 128.760 | 121.236 |
| Current Assets | - | - | 4.586 | 4.598 | 45.161 | 41.583 | 50.703 | 18.738 | 10.315 | 1.935 |
| Inventories | - | - | 0 | 114 | 111 | 0 | 407 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | -16 | 35.158 | 31.303 | 132 | 27 | 0 |
| Cash | - | - | 4.586 | 4.485 | 45.065 | 6.425 | 18.992 | 18.607 | 10.287 | 1.935 |
| Shareholders Funds | - | - | 4.430 | 5.414 | 7.888 | 15.255 | 35.822 | 70.042 | 85.330 | 83.555 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 156 | 184 | 38.077 | 26.945 | 17.469 | 85.020 | 53.745 | 39.616 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nevromed Activ Srl